AM

AMRZ

AMRZBasic MaterialsNASDAQ

Building Materials

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$11.81B
+0.9% YoY
Net Income
$1.19B
-7.0% YoY
EBITDA
$2.81B
-6.8% YoY
Free Cash Flow
$1.37B

Scan Results

Daily timeframe
DateIndicatorDetails
Jul 7 MACD Negative CrossoverHistogram -0.0661, negative momentum
Above MA200+1.0% from MA200, price crossed above
Jul 6 Above MA200+0.3% from MA200, price crossed above
MACD Negative CrossoverHistogram -0.0873, negative momentum
About AMRZ

Operating under the Building Materials umbrella, AMRZ is a basic materials company. Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America and Canada. At a $27.53B market cap, AMRZ ranks as a large-cap company within basic materials. It operates through two segments, Building Materials and Building Envelope.

Key stats
Market Cap$27.53B
P/E (TTM)24.50
Fwd P/E15.61
EPS$2.03
52W Change+0.3%
Dividend Yield0.22%
ROE10.1%
Analysis

On the balance sheet, AMRZ has $1.10B in cash with $7.10B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $1.37B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 10.1%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 5.0% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $10.73B to $11.81B.

AMRZ carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing AMRZ.

Links
More Basic Materials stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms